SEC Filing Summary for Robert M. Plenge

Robert M. Plenge, a director at BIOMARIN PHARMACEUTICAL INC (BMRN), acquired 6,140 shares of Common Stock on September 10, 2026. The acquisition was made through restricted stock units, with a reported price of $0.00, as noted in footnote F1. Following this transaction, Mr. Plenge directly owns 6,140 shares. The filing was made on September 14, 2026, and is designated as Form 4.